Sodium Thiosulfate
NDC 60267-705, Sodium Thiosulfate, injection, solution, from Hope Pharmaceuticals.
- Product NDC
- 60267-705
- Status
- Listed
- Labeler
- Hope Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203923
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60267-705 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM THIOSULFATE250 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60267-705-50 | 60267070550 | 50 mL in 1 VIAL, SINGLE-DOSE (60267-705-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/82f55408-2de9-463d-85e8-b39c3b259f0b
Use it
Look up 60267-705 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60267-705 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60267-705. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.